{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:49:05Z","timestamp":1791474545636,"version":"4.3.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:p>Noninvasive breast lesions encompass a heterogeneous group of risk indicators and nonobligate precursors of breast cancer, such as apocrine hyperplasia (AH) and columnar cell lesions (CCLs). Given the different expression of ER and ER-regulated genes in AH and CCL, these two alterations are currently considered discrete conditions. However, whether they share early biologic changes is not clear to date. Here, we sought to define the clinicopathologic and immunohistochemical features of a prospective series of combined lesions made up by CCLs and AH forming a continuum within single terminal duct-lobular units. The study group included 19 cases, whereas 25 cases of synchronous contiguous CCLs and AH served as control group. The different components of each case were subjected to immunohistochemical analysis for ER, PR, AR, HER2, BCL2, CCND1, MUC1, and PIP. Although CCLs and AHs arising in continuity showed opposite patterns of ER expression, the PIP-positive apocrine signature was consistently present in both components. In conclusion, apocrine changes are highly recurrent in CCLs growing within foci of AH, regardless of the ER activation. Our results suggest that PIP-positive and PIP-negative CCLs are likely to represent biologically distinct conditions and that apocrine changes might occur earlier than ER activation in the natural history of breast precursor lesions.<\/jats:p>","DOI":"10.1097\/pai.0000000000000604","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T17:10:49Z","timestamp":1509124249000},"page":"508-514","source":"Crossref","is-referenced-by-count":12,"title":["Columnar Cell Lesion and Apocrine Hyperplasia of the Breast: Is There a Common Origin? The Role of Prolactin-induced Protein"],"prefix":"10.1097","volume":"27","author":[{"given":"Amedeo","family":"Sciarra","sequence":"first","affiliation":[{"name":"Division of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Lopez","sequence":"additional","affiliation":[{"name":"Division of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Corti","sequence":"additional","affiliation":[{"name":"Division of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letterio","family":"Runza","sequence":"additional","affiliation":[{"name":"Division of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ercoli","sequence":"additional","affiliation":[{"name":"Division of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Bonometti","sequence":"additional","affiliation":[{"name":"Division of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Despini","sequence":"additional","affiliation":[{"name":"Breast Surgery Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Blundo","sequence":"additional","affiliation":[{"name":"Breast Surgery Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Gambini","sequence":"additional","affiliation":[{"name":"Oncology Unit, Fondazione IRCCS Ca\u2019 Granda\u2014Ospedale Maggiore Policlinico, via Francesco Sforza"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fusco","sequence":"additional","affiliation":[{"name":"Division of Pathology"},{"name":"Department of Biomedical, Surgical, and Dental Sciences, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2559.2010.03568.x","article-title":"Breast cancer precursors revisited: molecular features and progression pathways","volume":"57","author":"Lopez-Garcia","year":"2010","journal-title":"Histopathology"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/his.12897","article-title":"Infiltrating epitheliosis of the breast: characterization of histologic features, immunophenotype and genomic profile","volume":"68","author":"Eberle","year":"2015","journal-title":"Histopathology"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/path.4691","article-title":"Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations","volume":"238","author":"Guerini-Rocco","year":"2016","journal-title":"J Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/path.3990","article-title":"Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection","volume":"227","author":"Hernandez","year":"2012","journal-title":"J Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1586\/14737159.2015.1057125","article-title":"Molecular and diagnostic features of apocrine breast lesions","volume":"15","author":"Gromov","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/path.4566","article-title":"The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study","volume":"237","author":"Guerini-Rocco","year":"2015","journal-title":"J Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1136\/jcp.2006.040634","article-title":"Non-operative breast pathology: columnar cell lesions","volume":"60","author":"Pinder","year":"2007","journal-title":"J Clin Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00125480-200305000-00001","article-title":"Columnar cell lesions of the breast","volume":"10","author":"Schnitt","year":"2003","journal-title":"Adv Anat Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2559.2007.02888.x","article-title":"An update on apocrine lesions of the breast","volume":"52","author":"O'Malley","year":"2008","journal-title":"Histopathology"},{"key":"R12-20230922","first-page":"S3","article-title":"The histologic spectrum of apocrine lesions of the breast","volume":"113","author":"Durham","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1186\/1471-2407-14-546","article-title":"Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes","volume":"14","author":"Darb-Esfahani","year":"2014","journal-title":"BMC Cancer"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/jcp.2006.040626","article-title":"Non-operative breast pathology: apocrine lesions","volume":"60","author":"Wells","year":"2007","journal-title":"J Clin Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/modpathol.2012.228","article-title":"HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions","volume":"26","author":"Fusco","year":"2013","journal-title":"Mod Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"e0144923","DOI":"10.1371\/journal.pone.0144923","article-title":"The contrasting role of p16Ink4A patterns of expression in neuroendocrine and non-neuroendocrine lung tumors: a comprehensive analysis with clinicopathologic and molecular correlations","volume":"10","author":"Fusco","year":"2015","journal-title":"PLoS One"},{"key":"R17-20230922","first-page":"353","article-title":"Androgen receptor (AR) expression in 400 breast carcinomas: is routine AR assessment justified?","volume":"4","author":"Safarpour","year":"2014","journal-title":"Am J Cancer Res"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00428-002-0691-0","article-title":"Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast","volume":"441","author":"Selim","year":"2002","journal-title":"Virchows Arch"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/modpathol.3800621","article-title":"Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis","volume":"19","author":"Reis-Filho","year":"2006","journal-title":"Mod Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4048\/jbc.2013.16.2.152","article-title":"Associations between the expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and clinicopathologic parameters of human breast ductal carcinomas","volume":"16","author":"Do","year":"2013","journal-title":"J Breast Cancer"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/1097-0142(19890601)63:11<2156::AID-CNCR2820631115>3.0.CO;2-B","article-title":"Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors","volume":"63","author":"Mazoujian","year":"1989","journal-title":"Cancer"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5858\/arpa.2013-0953-SA","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"138","author":"Wolff","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1158\/1078-0432.CCR-15-2889","article-title":"Intra-tumor heterogeneity affects gene expression profile test prognostic risk stratification in early breast cancer","volume":"22","author":"Gyanchandani","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R25-20230922","first-page":"105","article-title":"Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features","volume":"110","author":"Mazoujian","year":"1983","journal-title":"Am J Pathol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1210\/endo.135.4.7925123","article-title":"Tissue-specific androgen-inhibited gene expression of a submaxillary gland protein, a rodent homolog of the human prolactin-inducible protein\/GCDFP-15 gene","volume":"135","author":"Myal","year":"1994","journal-title":"Endocrinology"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1309\/TDP92PQLDE2HLEET","article-title":"Mammaglobin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity","volume":"127","author":"Bhargava","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"e62361","DOI":"10.1371\/journal.pone.0062361","article-title":"Prolactin-induced protein (PIP) regulates proliferation of luminal A type breast cancer cells in an estrogen-independent manner","volume":"8","author":"Baniwal","year":"2014","journal-title":"PLoS One"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/bcr3232","article-title":"Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer","volume":"14","author":"Naderi","year":"2012","journal-title":"Breast Cancer Res"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.bbrc.2015.11.043","article-title":"Prolactin-induced protein regulates cell adhesion in breast cancer","volume":"468","author":"Vanneste","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0046-8177(91)90084-3","article-title":"Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary","volume":"22","author":"Monteagudo","year":"1991","journal-title":"Hum Pathol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-319-12114-7_8","article-title":"Prolactin-induced protein in breast cancer","volume":"846","author":"Naderi","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/j.1525-1438.2006.00664.x","article-title":"HER-2\/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications","volume":"16","author":"Villella","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.anndiagpath.2010.06.009","article-title":"Papillary apocrine metaplasia and columnar cell lesion with atypia: is there a shared common pathway?","volume":"14","author":"Kosemehmetoglu","year":"2010","journal-title":"Ann Diagn Pathol"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0002-9440(10)64543-9","article-title":"Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas","volume":"157","author":"Washington","year":"2000","journal-title":"Am J Pathol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1066896914548795","article-title":"The birth of an adenoid cystic carcinoma","volume":"23","author":"Fusco","year":"2014","journal-title":"Int J Surg Pathol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00428-008-0609-6","article-title":"Are columnar cell lesions the earliest histologically detectable non-obligate precursor of breast cancer?","volume":"452","author":"Turashvili","year":"2008","journal-title":"Virchows Arch"}],"container-title":["Applied Immunohistochemistry &amp; Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00129039-201908000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:11:36Z","timestamp":1695406296000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00129039-201908000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pai.0000000000000604","relation":{},"ISSN":["1541-2016"],"issn-type":[{"value":"1541-2016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}